AI-ASSISTED OPTIMIZATION OF NANOPARTICLE DRUG DELIVERY FOR ANTIDIABETIC THERAPY

Type 2 Diabetes Mellitus is one of the most current habitual metabolic diseases worldwide and requires effective long- term medicine remedy. Conventional medicine delivery systems frequently face limitations similar as poor bioavailability, on-targeted medicine distribution, and inconsistent remedial response. Nanoparticle- grounded medicine delivery systems have surfaced as a promising approach to ameliorate medicine stability, enhance immersion, and enable controlled medicine release. still, optimizing nanoparticle phrasings requires assessing multiple physicochemical and natural parameters, which can be complex and time consuming using traditional experimental styles.